Connect with us

Business

US shoulders disproportionate share of new drug development costs, report find

Published

on

US shoulders disproportionate share of new drug development costs, report find

New research by the Office of Health Policy shows the U.S. shoulders a disproportionate cost when it comes to paying for prescription medication.

The report, obtained by FOX Business, shows Americans account for nearly 80% of the innovative revenue for drugs launched between 2020 and 2025. The report also shows that no other country comes close to the United States’ contribution to shouldering the cost of research and development. The next-closest country paying the cost for R&D in that timeframe is Japan, which accounts for about 5.5% of innovative revenues for new medications coming online and roughly 5.8% of innovative revenues for all medications.

Advertisement

The U.S. trade representative’s office opened a new Section 301 investigation into Germany’s plan to reduce spending on pharmaceutical products on June 18. Germany accounts for nearly 3.4% of revenue for innovative medications from 2020 to 2025. The result of the investigation could allow President Donald Trump to make good on threats to add 100% tariffs on imports of pharmaceutical medications from Germany or tariffs on other imported goods from the country.

MERCK, SANOFI ARE LATEST COMPANIES TO ADD MEDICATIONS TO TRUMPRX

A pharmacy tech pulls medication from a shelf inside a pharmacy.

The U.S. trade representative’s office opened a new Section 301 investigation into Germany’s plan to reduce spending on pharmaceutical products on June 18. (George Frey/Bloomberg via Getty Images)

“I am particularly concerned with news that Germany is fast-tracking legislation that would further reduce its spending on innovative pharmaceuticals,” U.S. Trade Representative Jamieson Greer said in a statement. “This is a serious step backwards at a time when our trading partners need to step up and start paying their fair share to fund innovative pharmaceutical research and development.”

BRISTOL MYERS SQUIBB ADDING 3 MEDICATIONS ON TRUMPRX

Advertisement

The USTR is taking public comment on the investigation through Aug. 10. A public hearing related to the investigation will be held on Sept. 22.

Johnson & Johnson CEO Joaquin Duato told FOX Business Network’s “Mornings with Maria” this month that “We agree with the government that we have to make other countries pay their fair share, especially Europe. And at the same time, we have to work in the middleman. The middleman captures about 50% of the value of the medicine, and we want that value to go directly to the patient to reduce their out-of-pocket costs. So in those areas, the government is always going to find us, Johnson & Johnson, working with them.”

Ticker Security Last Change Change %
JNJ JOHNSON & JOHNSON 231.29 +2.90 +1.27%

Trump said in a Truth Social post earlier this month that, “Most Favored Nations would not be possible without my use of TARIFFS, which are getting other Countries to ‘pay up’ instead of relying on American Patients getting ripped off, as they were for decades until I ordered an immediate ‘stop’ to this very unfair and, frankly, foolish situation.”

RISING HEALTHCARE COSTS, INSURANCE PREMIUMS NOW WORRY AMERICANS MORE THAN ANY OTHER DOMESTIC ISSUE: POLL

Advertisement

Seventeen of the largest pharmaceutical companies signed deals for Most Favored Nations status for some medications.

Prescription medication in hand.

A person holds medication from a bottle in their hand. (Getty Images)

GET FOX BUSINESS ON THE GO BY CLICKING HERE

This new report from the Office of Health Policy could be used as a basis of proof that validates the concerns of the Trump administration that the costs Americans have been paying for medications are disproportionally high compared with the rest of the developed world.

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

ASX 200 Closes Week 2.5% Higher Near Five-Month High as Wall Street Tech Rally Lifts Sentiment Friday

Published

on

Australia Housing Market 2026: Two-Speed Boom Persists as Prices Hit

Australia’s benchmark stock index closed narrowly higher Friday, capping a strong week that pushed the S&P/ASX 200 close to a five-month high, as easing domestic inflation and a powerful overnight rally in U.S. technology stocks helped offset a pullback from the session’s earlier highs.

The S&P/ASX 200 finished up 0.10%, adding 9.3 points to close at 8,977.0, trading well below its intraday high after touching gains of as much as 1.03% earlier in the session. The pullback was most pronounced in the materials sector, which surged as much as 3.13% in early trade before easing back to close up 1.49%, part of a pattern of outsized daily swings that has characterized mining and resources stocks over the past eight trading sessions, according to analysis from Marketindex.com.au’s Kerry Sun. Despite the late-session fade, the ASX 200 closed the week 2.5% higher and trading close to a five-month high.

The rally traced its roots to a powerful overnight session on Wall Street. Major U.S. benchmarks pushed higher through the session and finished near their best levels, with the technology-heavy Nasdaq Composite jumping 2.7% to snap a six-day losing streak as investors returned to the artificial intelligence trade that has driven much of the market’s gains over the past year. The S&P 500 climbed 1.66% and the Dow Jones Industrial Average added 1.19% in the same session. Microsoft was the standout performer, surging more than 15% and adding roughly $450 billion in market capitalization in a single day, a record one-day gain in dollar value for any publicly traded company. Chipmakers broadly participated in the rebound as well, with the Philadelphia Semiconductor Index gaining 8%.

The overnight strength on Wall Street flowed directly into Australian trading. Futures markets had pointed to a sharply higher open in Sydney, with September SPI futures settling up 77 points, or 0.86%, at 9,012.5 ahead of the local session, after the ASX 200 had ended Thursday’s session 0.78% lower at 8,967.7 points, snapping what had been a winning streak for the index.

Advertisement

Domestic economic data released earlier in the week also contributed to the positive tone across Australian markets. A cooler-than-expected consumer price index reading published Wednesday eased some investor concerns about the pace of future interest rate moves from the Reserve Bank of Australia, adding to a generally constructive backdrop for equities heading into the week’s close.

Commodity markets showed a mixed picture that shaped individual sector performance within the index. Gold prices climbed sharply overnight, with futures rising 1.65% to $4,102.30 an ounce, a move that boosted sentiment toward gold miners including Evolution Mining and Newmont Corporation heading into Friday’s session. Iron ore prices also firmed, aided in part by strike threats affecting BHP Group’s operations, even as underlying demand signals out of China remained comparatively weak. Oil prices moved in the opposite direction, with Brent crude falling 16% since July 23 and closing down 1.88% at $89.03 a barrel in the most recent session, while U.S. crude dropped 1.03% to $83.59, a decline that weighed on energy-focused stocks including Santos and Woodside Energy Group even as both companies have continued to draw some support from concerns about ongoing Middle East shipping risks.

Lithium stocks drew renewed analyst attention during the week following quarterly production updates. Brokerage Bell Potter maintained its speculative buy rating on Vulcan Energy Resources while trimming its price target to $4.50 from $6.10, and held its hold rating on Pilbara Minerals while cutting its target to $4.70 from $6.15. Commenting on Pilbara Minerals specifically, Bell Potter said the company “will generate substantial earnings and cash flow with the restart of the 200ktpa Ngungaju processing plant” at current lithium market prices, while noting that its P2000 and Colina development studies “are being progressed, providing substantial organic growth optionality in markets with strong underlying EV and BESS-led long term demand fundamentals.”

Longer-term bond yields presented a potential headwind for growth-oriented stocks heading into the new trading week. The U.S. 30-year Treasury yield reached its highest level in 19 years during the week, a development that analysts said could constrain further gains in growth-sensitive sectors of the market if the trend continues, even as the immediate market reaction to this week’s data and earnings news remained broadly positive.

Advertisement

With the ASX 200 now trading above levels implied by at least two previously stated year-end forecasts from market strategists, analysts have begun flagging a more complex outlook heading into the second half of the year, noting that earnings expectations for sectors outside of mining and banking have started to tighten even as those two dominant sectors have continued to anchor the index’s overall performance. Wood Mackenzie separately forecast that continued turbulence in Middle East oil markets could help lift global upstream oil and gas free cash flow to $495 billion in 2026, provided Brent crude prices average around $90 per barrel over the course of the year, underscoring how closely tied energy sector earnings outlooks remain to the trajectory of the ongoing geopolitical situation.

With a busy stretch of corporate earnings and economic data still ahead, investors are likely to watch closely whether the current wave of positive momentum from U.S. technology stocks can be sustained into the new trading week, particularly as questions persist about bond yield pressure, energy price volatility and the durability of the artificial intelligence-driven rally that powered Thursday night’s rebound on Wall Street.

Continue Reading

Business

Cornwall Airport Newquay could reintroduce passenger levy to help cover running costs

Published

on

Business Live

The cash-strapped transport hub continues to struggle financially

A plane taking off in a sunset

A plane taking off(Image: Steve Parsons/PA Wire)

The prospect of Newquay Airport ever becoming financially self-sufficient without the backing of Cornish taxpayers remains a distant reality. That was the stark message delivered at Cornwall Council meetings this week.

Advertisement

Having agreed to prop up the airport’s operations to the tune of more than £5.8m over the coming year, Cornwall councillors have been exploring the possibility of reintroducing a passenger levy to boost income.

Newquay Airport previously operated a levy known as the Airport Development Fee (ADF), a £5 charge applied to departing passengers aged 16 and over. Cornwall Council officially axed the contentious charge a decade later in March 2016 in a bid to drive passenger growth and attract new airline routes.

Meetings of Cornwall Council’s corporate finance scrutiny committee and its Liberal Democrat/Independent cabinet heard this week that the airport – which has perpetually struggled to turn a profit – is facing mounting pressure following the collapse of Eastern Airways and the council’s decision to scrap the subsidised Public Service Obligation (PSO) route to London Gatwick earlier this year.

In response, Corserv – the council-owned company that operates the airport – is set to unveil a transformation plan later this year. Alongside the commercial development of the surrounding airport estate, this could involve introducing alternative revenue streams such as drone operations, defence contracts and an expanded offering at Spaceport Cornwall, which is situated at the airport.

Advertisement

Corserv chief executive Neil Edmond told the finance scrutiny committee this week the airport requires more than a million passengers a year to cover its operating costs – a figure that will realistically never be achieved given its geographical location.

The committee was informed that the airport will be unable to function without financial support for at least the next four to five years, although it was hoped this reliance on subsidy could be reduced over time.

Cllr Rowland O’Connor voiced concerns that every single day the airport remains operational it is heaping further financial pressure on other areas of the council. He also highlighted the suspension of capital maintenance at the airport, which has been deferred for a year.

“It is absolutely amazing that we are deferring routine maintenance. From an outsider in, I’d be asking what safety implications does that have,” he said.

Advertisement

As part of its recommendations to cabinet, the committee called on the administration to “urgently reviews an airport passenger fee to maximise income”.

Council leader Cllr Leigh Frost confirmed it was something his cabinet would “absolutely look at”.

Cllr Martyn Alvey urged restraint, noting that the previous Conservative administration – of which he was a member – had considered reintroducing a passenger levy but “kicked it into touch” after concluding it was not a viable option.

Advertisement
Continue Reading

Business

Fuchs confirms second quarter results with strong sales growth

Published

on


Fuchs confirms second quarter results with strong sales growth

Continue Reading

Business

NV Bekaert SA (BEKAY) Q2 2026 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript